Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 552 results for "Tecfidera"

High Costs For Drugs Used By A Few Are Starting To Add Up
NPR

High Costs For Drugs Used By A Few Are Starting To Add Up

Multiple sclerosis pill Tecfidera is on the top 10 list of most costly specialty drugs, as measured by overall spending, for California's health benefit system for public workers and retirees. John/Flickr hide caption toggle caption John/Flickr ... NPR, 4 days ago
Multiple sclerosis drugs to receive funding FirstWord Pharma, 2 months ago

6 images for Tecfidera

NPR, 4 days ago
New Zealand Herald, 1 week ago
Radio New Zealand, 1 week ago
Proactive Investors USA, 1 week ago
Bidness Etc, 2 weeks ago
Nine MSN The Fix, 2 weeks ago

Tecfidera Raised Its Share of Contribution to Overall Revenue

Good Medicine: Biogen's 4Q15 and 2015 Earnings Beat Estimates ( Continued from Prior Part ) Revenues from Tecfidera Tecfidera is one of the major drugs in Biogen's (BIIB) strong portfolio of multiple sclerosis treatments. Tecfidera is an oral ...
 Yahoo! Finance1 week ago Biogen posts higher fourth-quarter revenue as Tecfidera sales rise  FirstWord Pharma2 weeks ago

Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Revision: 5, Authorised

This is a summary of the European public assessment report (EPAR) for Tecfidera. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on ...
 European Medicines Agency1 week ago

Biogen's profit blows past estimates as Tecfidera sales rise

* Fourth-quarter revenue beats expectation * Tecfidera quarterly sales above analysts' estimate * Shares rise 5.6 pct premarket (Adds 2016 forecast, details, analysts' comment; updates shares) Jan 27 (Reuters) - Biogen Inc's quarterly profit ...
 Sharenet2 weeks ago UPDATE 2-Biogens profit blows past estimates as Tecfidera sales rise  Reuters1 week ago

Biogen sees new Tecfidera buzz as DTC, marketing push kicks in

Biogen's multiple sclerosis superstar Tecfidera turned into a laggard last year after the FDA raised new safety questions. But if dollar signs are any indicator, a new advertising and marketing push--and a higher price--have helped put the brand ...
 FiercePharmaMarketing6 days ago

Tecfidera® (Dimethyl Fumarate) Funded in New Zealand

New Zealand multiple sclerosis (MS) patients will soon have affordable access to an additional option for the treatment of relapsing multiple sclerosis (MS) with news that PHARMAC will fund TECFIDERA® (dimethyl fumarate). TECFIDERA, supplied by ...
 MyInforms1 week ago Pharmac to fund new medicine for MS  Voxy.co.nz1 week ago New EMA Advice for PML Prevention With Fingolimod in MS  RxList1 month ago
InvestorPlace.com

Biogen Inc Looking Better After Earnings (BIIB)

Popular Posts: Recent Posts: OK, so maybe sales of Biogen Inc ( BIIB ) multiple sclerosis drug Tecfidera aren't so anemic after all. The market had grown concerned after sales of the greatly ballyhooed drug started to slow down last year … ...
 InvestorPlace.com1 week ago

Revved-up Tecfidera sales power Biogen in Q4

Biogen CEO George Scangos Biogen ( $BIIB ) CEO George Scangos and his team tamped down investor expectations earlier this month at the J.P. Morgan Healthcare Conference, saying that the company faced headwinds. But the drugmaker got those winds ...
 FiercePharma1 week ago

Biogen profit beats Street estimates as Tecfidera shines

(Adds details, estimates) Jan 27 (Reuters) - Biogen Inc's quarterly profit breezed past Wall Street's estimates, driven by higher demand for its key oral multiple sclerosis drug Tecfidera. The U.S. biotechnology company's shares rose about 7 ...
 Sharenet2 weeks ago UPDATE 1-Biogen profit beats Street estimates as Tecfidera shines  MyInforms2 weeks ago

FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)

The U.S. Food and Drug Administration (FDA) is warning that a patient with multiple sclerosis (MS) who was being treated with Tecfidera (dimethyl fumarate), developed a rare and serious brain infection called PML, and later died. As a result, ...
 U.S. Food and Drug Administration3 weeks ago Fourth PML Case With Tecfidera in MS Calls for Vigilance  MyInforms1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Tecfidera
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less